Hub Genes in Non-Small Cell Lung Cancer Regulatory Networks

There are currently no accurate biomarkers for optimal treatment selection in early-stage non-small cell lung cancer (NSCLC). Novel therapeutic targets are needed to improve NSCLC survival outcomes. This study systematically evaluated the association between genome-scale regulatory network centralit...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Qing, Guo, Nancy Lan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776006/
https://www.ncbi.nlm.nih.gov/pubmed/36551208
http://dx.doi.org/10.3390/biom12121782

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776006/
https://www.ncbi.nlm.nih.gov/pubmed/36551208
http://dx.doi.org/10.3390/biom12121782

Ejemplares similares